INSIGHTS ON DRUG DEVELOPMENT
-
Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency
Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.
-
Lightning-Link® Conjugation Kits: Consistent Performance On A Broad Scale
Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.
-
Solid Formulation: Spray Drying Process
Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.
-
Customer Spotlight: Queen Mary University Of London's Centre For Predictive In Vitro Models
Discover the future of in vitro modeling at the Queen Mary+Emulate Organs-on-Chips Centre and unlock new possibilities in the field of predictive medicine.
-
Project Management: Sphere Of Influence10/21/2024
The project manager's sphere of influence extends beyond the project team, encompassing the organization, industry, and professional discipline.
-
Accelerate Your pDNA And mRNA Process Development11/13/2025
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Improving API Solubility With Mesoporous Silica6/5/2025
Poor solubility of active pharmaceutical ingredients can hinder drug effectiveness. Learn how innovative formulation strategies enhance solubility and bioavailability to improve therapeutic outcomes for challenging drug candidates.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development1/15/2026
Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
DRUG DEVELOPMENT SOLUTIONS
-
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
Genedata Profiler empowers biopharma R&D by integrating, harmonizing, and analyzing diverse data, enhancing collaboration, accelerating insights, and reducing costs for precision medicine advancement.
-
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Explore imaging, fluorescence, and luminescence-based techniques for cell analysis, viability, and gene expression, as well as how multimode readers streamline workflows and enhance data quality.